402 studies were excluded after the full-text screening. Ultimately, 23 reviews (Ramesh et al. 2013, Viana and Ignotti 2013, Fan et al. 2015, Philipsborn et al. 2016, Cheng et al. 2018, Ghazani et al. 2018, Lu et al. 2018, Bai et al. 2019, Chen et al. 2019, Coates et al. 2019, Popovic et al. 2019, Asadgol et al. 2020, Copat et al. 2020, Li et al. 2020, Villeneuve and Goldberg 2020, Katoto et al. 2021, Liang et al. 2021, Majumder and Ray 2021, Maleki et al. 2021, Meo et al. 2021, Starke et al. 2021, Xiang et al. 2021, Zang et al. 2022 ) met the inclusion criteria (Figure S1). 15 systematic reviews evaluated morbidity, 7 reviews evaluated both morbidity and mortality, and mortality was evaluated in only one review. 9 were pollutant-related, and 14 were temperature-related, covering ten infectious diseases (Table S3). Three statements were adopted in the included studies: PRISMA, MOOSE and STROBE, both Zang et al. and Asadgol et al. used PRISMA and MOOSE together, while seven studies, it was not mentioned which statement was adopted. In addition, three (13%) studies adopted the GRADE (Grading of Recommendations Assessment, Development and Evaluation).
3.1 Quality assessment of systematic reviews
As presented in Figure S2, the results of the quality assessment showed that three studies were of low quality (13%) and 20 articles were of critically low quality (87%). Item 1 (100%), item 4 (100%), Item 8 (100%), Item 11 (100%) and Item 16 (96%) denoted satisfactory results, whereas Item 3 (0%), Item 7 (0%) and Item 10 (0%) reported inadequately. Item 2 was poorly reported and most systematic reviews were not registered, however studies on COVID-19 (28.6%) and infectious diarrhea (50%) satisfied this criterion better. AMSTAR-2 scores of systematic reviews with and without meta-analyses are presented in Table S4.
3.2 Findings from the overview
3.2.1 Exposure risk assessment of short-term exposure to air pollutants on infectious diseases
Nine pollutant-related studies were included, six of which were systematic reviews (Popovic et al. 2019, Copat et al. 2020, Villeneuve and Goldberg 2020, Katoto et al. 2021, Maleki et al. 2021, Meo et al. 2021), and three were meta-analyses (Chen et al. 2019, Xiang et al. 2021, Zang et al. 2022) (Fig. 1). In addition, in nine studies, the association between short-term exposure to air pollutants and infectious morbidity and mortality was analyzed.
One meta-analysis and five systematic reviews analyzed the association between COVID-19 and pollutants: Zang et al. 2022 performed a meta-analysis on the association, which indicated that short-term exposure to NO2 (RR 1.014 per 1 \({\mu }\text{g}/\text{m}\)3, 95% CI: 1.011–1.016), O3 (RR 1.001 per 1 \({\mu }\text{g}/\text{m}\)3, 95% CI: 1.000-1.002), PM10 (RR 1.005 per 1 \({\mu }\text{g}/\text{m}\)3, 95% CI: 1.003–1.008), PM2.5 (RR 1.003 per 1 \({\mu }\text{g}/\text{m}\)3, 95% CI: 1.002–1.004) and SO2 (RR 1.015 per 1 \({\mu }\text{g}/\text{m}\)3, 95% CI: 1.007–1.023) were positively associated to COVID-19 morbidity, with CO had no statistical significance.
One meta-analysis focused on the association between air pollution and conjunctivitis. It indicated that NO2 and O3 increased the risk of conjunctivitis morbidity (Chen et al. 2019). One meta-analysis and one systematic review analyzed the exposure risks of pollutants on tuberculosis (TB), while the results were controversial: Popovic et al.2019 showed that PM2.5 may be associated with culture-positive TB morbidity.. Compared to the results of Xiang et al. 2021, a meta-analysis, showed that short-term exposure to pollution (PM2.5: RR 1.003 per 1 \({\mu }\text{g}/\text{m}\)3, 95% CI: 0.998–1.008) was not associated with TB morbidity.
Figure 1 Forest plot for the effects of short-term exposure to pollutants on infectious diseases.
3.2.2 Exposure risk assessment of long-term exposure to air pollutants on infectious diseases
Eight studies (Popovic et al. 2019, Copat et al. 2020, Villeneuve and Goldberg 2020, Katoto et al. 2021, Maleki et al. 2021, Meo et al. 2021, Xiang et al. 2021, Zang et al. 2022) conducted the association between long-term exposure to air pollutants and the morbidity and mortality outcomes of infectious diseases, and two were meta-analyses (Xiang et al. 2021, Zang et al. 2022) (Fig. 2).
One meta-analysis and five systematic reviews, the association between COVID-19 and pollution was analyzed: Zang et al. 2022 showed that COVID-19 morbidity was positively associated with long-term exposure to 1 \({\mu }\text{g}/\text{m}\)3 increase in PM2.5 (RR 1.056 per 1 \({\mu }\text{g}/\text{m}\)3, 95% CI: 1.039–1.072, I2 = 94.9%), NO2 (RR 1.042 per 1 \({\mu }\text{g}/\text{m}\)3, 95% CI: 1.017–1.068, I2 = 98.3%), and SO2 (RR 1.071 per 1 \({\mu }\text{g}/\text{m}\)3, 95% CI: 1.002–1.145, I2 = 97.2%). However, COVID-19 morbidity was negatively associated with CO (RR 0.258 per 1 \({\mu }\text{g}/\text{m}\)3, 95% CI: 0.126–0.529, I2 = 99.4%) and O3 (RR 0.983 per 1 \({\mu }\text{g}/\text{m}\)3, 95% CI: 0.972–0.994, I2 = 98.4%). Katoto et al. 2021 was a systematic review, which indicated a highly positive association between long-term exposure to PM2.5 and COVID-19 morbidity.
One meta-analysis and one systematic review analyzed the association between TB and pollutants, with controversial results: Xiang et al. 2021 showed that long-term exposure to PM10 (RR 1.006 per 1 \({\mu }\text{g}/\text{m}\)3, 95%CI 1.002–1.009) and NO2 (RR 1.005 per 1 \({\mu }\text{g}/\text{m}\)3, 95%CI 1.001–1.008) was significantly associated with TB morbidity. In addition, Popovic et al. 2019 suggested that SO2 may be a potential protective factor for TB.
3.2.3 Exposure risk assessment of temperatures on infectious diseases
Fourteen temperature-related studies were included, among which were 8 systematic reviews (Ramesh et al. 2013, Viana and Ignotti 2013, Ghazani et al. 2018, Lu et al. 2018, Bai et al. 2019, Coates et al. 2019, Asadgol et al. 2020, Starke et al. 2021) and 6 meta-analyses (Fan et al. 2015, Philipsborn et al. 2016, Cheng et al. 2018, Li et al. 2020, Liang et al. 2021, Majumder and Ray 2021) (Fig. 3).
One meta-analysis and one systematic review analyzed the association between temperatures and COVID-19: Majumder and Ray 2021 showed that temperature was associated with COVID-19 morbidity (pooled correlation = 0.230, 95% CI: 0.010–0.430). However, the correlation between temperatures and COVID-19 mortality (pooled correlation = 0.210, 95% CI: -0.140-0.520) was not statistically significant. However, a systematic review by Starke et al. 2021, indicated that an elevated temperature maybe was a protective factor for COVID-19 mortality.
Per 1°C increase in temperatures was associated with dengue, infectious diarrhoea, trachoma, hemorrhagic fever with renal syndrome and HFMD morbidity. Fan et al. 2015, Li et al. 2020 showed that dengue morbidity increased by 13% (RR = 1.130 per 1°C, 95% CI: 1.120–1.150), within the average temperature range of 23.2–27.7°C was most closely and positively correlated. The morbidity of infectious diarrhea increased 8% (RR = 1.080 per 1°C, 95% CI: 1.050–1.200), and Diarrhoeal Escherichia coli increased 10% (RR 1.100 per 1°C, 95% CI: 1.050–1.200, P < 0.0001). While increased temperatures were negatively correlated with Helicobacter pylori infection (coefficient=-0.577, P < 0.001, coefficient =-0.556, P < 0.001) (Philipsborn et al. 2016, Lu et al. 2018, Liang et al. 2021, Asadgol et al. 2020). Cheng et al. 2018 indicated that HFMD morbidity increased 5% (RR 1.050 per 1°C, 95% CI: 1.020–1.080), especially in a subtropical climate zone (RR 1.060 per 1°C, 95% CI: 1.020–1.100).